PURPOSE: Most craniofacial birth defects contain skeletal components that require bone grafting. Although many growth factors have shown potential for use in bone regeneration, bone morphogenetic proteins (BMPs) are the most osteoinductive. However, supraphysiologic doses, high cost, and potential adverse effects stimulate clinicians and researchers to identify complementary molecules that allow a reduction in dose of BMP-2. Because NELL1 plays a key role as a regulator of craniofacial skeletal morphogenesis, especially in committed chondrogenic and osteogenic differentiation, and a previous synergistic mechanism has been identified, NELL1 is an ideal molecule for combination with BMP-2 in calvarial defect regeneration. We investigated the effect of NELL1 and BMP-2 on bone regeneration in vivo. MATERIALS AND METHODS: BMP-2 doses of 589 and 1,178 ng were grafted into 5-mm critical-sized rat calvarial defects, as compared with 589 ng of NELL1 plus 589 ng of BMP-2 and 1,178 ng of NELL1 plus 1,178 ng of BMP-2, and bone regeneration was analyzed. RESULTS: Live micro-computed tomography data showed increased bone formation throughout 4 to 8 weeks in all groups but a significant improvement when the lower doses of each molecule were combined. High-resolution micro-computed tomography and histology showed more mature and complete defect healing when the combination of NELL1 plus BMP-2 was compared with BMP-2 alone at lower doses. CONCLUSION: The observed potential synergy has significant value in the future treatment of patients with craniofacial defects requiring extensive bone grafting that would normally entail extraoral autogenous bone grafts or doses of BMP-2 in milligrams. Copyright 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
PURPOSE: Most craniofacial birth defects contain skeletal components that require bone grafting. Although many growth factors have shown potential for use in bone regeneration, bone morphogenetic proteins (BMPs) are the most osteoinductive. However, supraphysiologic doses, high cost, and potential adverse effects stimulate clinicians and researchers to identify complementary molecules that allow a reduction in dose of BMP-2. Because NELL1 plays a key role as a regulator of craniofacial skeletal morphogenesis, especially in committed chondrogenic and osteogenic differentiation, and a previous synergistic mechanism has been identified, NELL1 is an ideal molecule for combination with BMP-2 in calvarial defect regeneration. We investigated the effect of NELL1 and BMP-2 on bone regeneration in vivo. MATERIALS AND METHODS:BMP-2 doses of 589 and 1,178 ng were grafted into 5-mm critical-sized rat calvarial defects, as compared with 589 ng of NELL1 plus 589 ng of BMP-2 and 1,178 ng of NELL1 plus 1,178 ng of BMP-2, and bone regeneration was analyzed. RESULTS: Live micro-computed tomography data showed increased bone formation throughout 4 to 8 weeks in all groups but a significant improvement when the lower doses of each molecule were combined. High-resolution micro-computed tomography and histology showed more mature and complete defect healing when the combination of NELL1 plus BMP-2 was compared with BMP-2 alone at lower doses. CONCLUSION: The observed potential synergy has significant value in the future treatment of patients with craniofacial defects requiring extensive bone grafting that would normally entail extraoral autogenous bone grafts or doses of BMP-2 in milligrams. Copyright 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Authors: K Ting; H Vastardis; J B Mulliken; C Soo; A Tieu; H Do; E Kwong; C N Bertolami; H Kawamoto; S Kuroda; M T Longaker Journal: J Bone Miner Res Date: 1999-01 Impact factor: 6.741
Authors: Frank Berger; Yu-Po Lee; Andreas M Loening; Arion Chatziioannou; Stephen J Freedland; Richard Leahy; Jay R Lieberman; Arie S Belldegrun; Charles L Sawyers; Sanjiv S Gambhir Journal: Eur J Nucl Med Mol Imaging Date: 2002-09 Impact factor: 9.236
Authors: Brian P Dickinson; Rebekah K Ashley; Kristy L Wasson; Catherine O'Hara; Joubin Gabbay; Justin B Heller; James P Bradley Journal: Plast Reconstr Surg Date: 2008-01 Impact factor: 4.730
Authors: Ramakrishnaiah Siddappa; Anton Martens; Joyce Doorn; Anouk Leusink; Cristina Olivo; Ruud Licht; Linda van Rijn; Claudia Gaspar; Riccardo Fodde; Frank Janssen; Clemens van Blitterswijk; Jan de Boer Journal: Proc Natl Acad Sci U S A Date: 2008-05-19 Impact factor: 11.205
Authors: Rebekah M Samsonraj; Amel Dudakovic; Pengfei Zan; Oksana Pichurin; Simon M Cool; Andre J van Wijnen Journal: Tissue Eng Part C Methods Date: 2017-07-03 Impact factor: 3.056
Authors: Björn Behr; Michael Sorkin; Marcus Lehnhardt; Andrea Renda; Michael T Longaker; Natalina Quarto Journal: Tissue Eng Part A Date: 2012-02-28 Impact factor: 3.845
Authors: Sandy R Larson; Xiaotun Zhang; Ruth Dumpit; Ilsa Coleman; Bryce Lakely; Martine Roudier; Celestia S Higano; Lawrence D True; Paul H Lange; Bruce Montgomery; Eva Corey; Peter S Nelson; Robert L Vessella; Colm Morrissey Journal: Prostate Date: 2013-01-17 Impact factor: 4.104